Global Vital Proteins for Biomanufacturing Market by Groups (Cytokines, Enzymes & Chemicals, Expression Systems), Function (Diagnostics, Drug Discovery & Development), Indication - Forecast 2024-2030- Product Image

Sale

Global Vital Proteins for Biomanufacturing Market by Groups (Cytokines, Enzymes & Chemicals, Expression Systems), Function (Diagnostics, Drug Discovery & Development), Indication - Forecast 2024-2030

Report
187 Pages
March 2024
Region: Global
360iResearch™
ID: 5889105

UP TO €846EUR$875USD£717GBP OFF until Dec 31^st 2024

The Vital Proteins for Biomanufacturing Market size was estimated at USD 52.10 billion in 2023, USD 56.52 billion in 2024, and is expected to grow at a CAGR of 8.92% to reach USD 94.81 billion by 2030.

Vital proteins for biomanufacturing encompasses the production, distribution, and utilization of essential protein products derived from biological sources that have significant applications in various industries, such as pharmaceuticals, biotechnology, and medicine. These proteins are integral to cell growth, development, and overall function in living organisms. They also play a crucial role in manufacturing biopharmaceuticals, diagnostics, vaccines, cell therapies, and other biomaterial products. Increasing demand for biopharmaceuticals with enhanced therapeutic efficacy, advancements in recombinant DNA technology allowing high-level expression of foreign genes, and rapid adoption of novel cell culture platforms to produce complex biotherapeutics significantly drive the market growth. However, high capital expenditure requirements for establishing state-of-the-art biomanufacturing facilities and complexities associated with scaling up production processes may hinder market adoption. Adopting artificial intelligence (AI) and machine learning algorithms can accelerate protein design, improve yields, and optimize process conditions, and investments in advanced analytical techniques are expected to create a lucrative market opportunity in the forecast period.

Regional Insights

The Americas has a significant presence in the vital proteins for the Biomanufacturing market due to substantial investments by key players to enhance their capabilities in the market. Regulatory agencies, including the U.S. FDA and Health Canada, work diligently to meet safety standards and have implemented guidelines governing Good Manufacturing Practices(GMPs) for vital protein production. The European Union and the United Kingdom boast strong biotech sectors supported by robust R&D capabilities. The Middle East & Africa region has observed massive growth in recent years due to raised investment in healthcare infrastructure. The Asia-Pacific (APAC) region holds significant potential in the biomanufacturing sector, particularly in the field of vital proteins, which can be attributed to various factors such as rapid advancements in technology, expanding pharmaceutical and biotechnology industries, favorable government policies, and increased investments in research and development.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Vital Proteins for Biomanufacturing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Vital Proteins for Biomanufacturing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Vital Proteins for Biomanufacturing Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Abnova Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BioLegend, Inc. by PerkinElmer, Inc., Biologics International Corporation, BPS Bioscience, Inc., Bristol-Myers Squibb Company, Creative BioMart Inc., Croyez Bioscience Co., Ltd., Eli Lilly and Company, Enzo Life Sciences, Inc., GenScript Biotech Corporation, Johnson & Johnson Services, Inc., Laurus Bio Private Limited, LenioBio GmbH, Lonza Group AG, Merck KGaA, Meridian Bioscience, Inc. by SD Biosensor Inc., Miltenyi Biotec B.V. & Co. KG, Novartis AG, ProMab Biotechnologies, Inc., and Thermo Fisher Scientific Inc.

Market Segmentation & Coverage

This research report categorizes the Vital Proteins for Biomanufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Groups
- Cytokines
  - Chemokines
  - Colony-stimulating factors
  - Interferons
  - Interleukins
  - Tumor necrosis factors
- Enzymes & Chemicals
  - DNA Capping Enzymes
  - Endonucleases
  - Glycosidases
  - Polyadenylation Enzymes
  - Protease Inhibitors
  - Transcription Enzymes
- Expression Systems
  - Bacterial
  - Insect
  - Mammalian Cells
  - Yeast
- Media & Supplements
  - Albumin
  - Epidermal Growth Factor (EGF)
  - Fibroblast Growth Factors (FGFs)
  - Insulin-like Growth Factors (IGFs)
  - Transferrin
  - Vascular Endothelial Growth Factor (VEGF)
- Protein A Resins
- Quality Control Reagents
- Vectors & Transfection Reagents
Function
- Diagnostics
- Drug Discovery & Development
  - Biologics
  - Cell & Gene Therapy
  - Vaccines
Indication
- Autoimmune Disorders
- Infectious Diseases
- Oncology
- Rare Genetic Disorders

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Vital Proteins for Biomanufacturing Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Vital Proteins for Biomanufacturing Market?
What are the technology trends and regulatory frameworks in the Vital Proteins for Biomanufacturing Market?
What is the market share of the leading vendors in the Vital Proteins for Biomanufacturing Market?
Which modes and strategic moves are suitable for entering the Vital Proteins for Biomanufacturing Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Vital Proteins for Biomanufacturing Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for biopharmaceuticals with enhanced therapeutic efficacy
5.1.1.2. Rapid adoption of novel cell culture platforms to produce complex biotherapeutics
5.1.1.3. Growing interest in personalized medicine necessitates tailored protein therapeutics
5.1.2. Restraints
5.1.2.1. High capital expenditure requirements for establishing state-of-the-art biomanufacturing facilities
5.1.3. Opportunities
5.1.3.1. Supportive government policies promoting investments in research & development
5.1.3.2. Ongoing collaborations between academia & industry players for technological innovations in vital proteins
5.1.4. Challenges
5.1.4.1. Complexities associated with scaling up production processes
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Vital Proteins for Biomanufacturing Market, by Groups

6.1. Introduction
6.2. Cytokines
6.3.1. Chemokines
6.3.2. Colony-stimulating factors
6.3.3. Interferons
6.3.4. Interleukins
6.3.5. Tumor necrosis factors
6.3. Enzymes & Chemicals
6.4.1. DNA Capping Enzymes
6.4.2. Endonucleases
6.4.3. Glycosidases
6.4.4. Polyadenylation Enzymes
6.4.5. Protease Inhibitors
6.4.6. Transcription Enzymes
6.4. Expression Systems
6.5.1. Bacterial
6.5.2. Insect
6.5.3. Mammalian Cells
6.5.4. Yeast
6.5. Media & Supplements
6.6.1. Albumin
6.6.2. Epidermal Growth Factor (EGF)
6.6.3. Fibroblast Growth Factors (FGFs)
6.6.4. Insulin-like Growth Factors (IGFs)
6.6.5. Transferrin
6.6.6. Vascular Endothelial Growth Factor (VEGF)
6.6. Protein A Resins
6.7. Quality Control Reagents
6.8. Vectors & Transfection Reagents

7. Vital Proteins for Biomanufacturing Market, by Function

7.1. Introduction
7.2. Diagnostics
7.3. Drug Discovery & Development
7.4.1. Biologics
7.4.2. Cell & Gene Therapy
7.4.3. Vaccines

8. Vital Proteins for Biomanufacturing Market, by Indication

8.1. Introduction
8.2. Autoimmune Disorders
8.3. Infectious Diseases
8.4. Oncology
8.5. Rare Genetic Disorders

9. Americas Vital Proteins for Biomanufacturing Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Vital Proteins for Biomanufacturing Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Vital Proteins for Biomanufacturing Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Merger & Acquisition
12.3.1.1. Everest Medicines Ltd. acquires rights to 3C-like protease inhibitors to develop antivirals for COVID-19
12.3.2. New Product Launch & Enhancement
12.3.2.1. New England Biolabs Introduces Faustovirus Capping Enzyme, a Novel Enzymatic mRNA Capping Solution for mRNA Manufacturing

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. Abcam PLC
13.1.2. Abnova Corporation
13.1.3. Agilent Technologies, Inc.
13.1.4. Bio-Rad Laboratories, Inc.
13.1.5. BioLegend, Inc. by PerkinElmer, Inc.
13.1.6. Biologics International Corporation
13.1.7. BPS Bioscience, Inc.
13.1.8. Bristol-Myers Squibb Company
13.1.9. Creative BioMart Inc.
13.1.10. Croyez Bioscience Co., Ltd.
13.1.11. Eli Lilly and Company
13.1.12. Enzo Life Sciences, Inc.
13.1.13. GenScript Biotech Corporation
13.1.14. Johnson & Johnson Services, Inc.
13.1.15. Laurus Bio Private Limited
13.1.16. LenioBio GmbH
13.1.17. Lonza Group AG
13.1.18. Merck KGaA
13.1.19. Meridian Bioscience, Inc. by SD Biosensor Inc.
13.1.20. Miltenyi Biotec B.V. & Co. KG
13.1.21. Novartis AG
13.1.22. ProMab Biotechnologies, Inc.
13.1.23. Thermo Fisher Scientific Inc.
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. VITAL PROTEINS FOR BIOMANUFACTURING MARKET RESEARCH PROCESS
FIGURE 2. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, 2023 VS 2030
FIGURE 3. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. VITAL PROTEINS FOR BIOMANUFACTURING MARKET DYNAMICS
FIGURE 7. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2023 VS 2030 (%)
FIGURE 8. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
FIGURE 10. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. VITAL PROTEINS FOR BIOMANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 6. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 8. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CHEMOKINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COLONY-STIMULATING FACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INTERFERONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INTERLEUKINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY TUMOR NECROSIS FACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 15. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DNA CAPPING ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENDONUCLEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GLYCOSIDASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY POLYADENYLATION ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PROTEASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY TRANSCRIPTION ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 23. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INSECT, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY YEAST, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 29. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EPIDERMAL GROWTH FACTOR (EGF), BY REGION, 2018-2030 (USD MILLION)
TABLE 31. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FIBROBLAST GROWTH FACTORS (FGFS), BY REGION, 2018-2030 (USD MILLION)
TABLE 32. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INSULIN-LIKE GROWTH FACTORS (IGFS), BY REGION, 2018-2030 (USD MILLION)
TABLE 33. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY TRANSFERRIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF), BY REGION, 2018-2030 (USD MILLION)
TABLE 35. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PROTEIN A RESINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY QUALITY CONTROL REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY VECTORS & TRANSFECTION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 39. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 42. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CELL & GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY RARE GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 76. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 77. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 78. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 79. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 80. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 81. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 82. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 84. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 85. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 86. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 87. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 88. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 89. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 90. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 110. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 111. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 117. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 118. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 119. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 120. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 121. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 122. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 123. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 124. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 125. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 126. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 127. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 128. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 129. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 130. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 131. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 132. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 133. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 134. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 135. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 136. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 137. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 138. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 139. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 140. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 141. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 142. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 143. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 144. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 145. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 146. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 147. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 148. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 149. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 150. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 151. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 152. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 153. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 154. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 155. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 156. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 157. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 158. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 159. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 160. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 161. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 162. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 163. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 164. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 165. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 166. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 167. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 168. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 169. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 170. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 171. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 172. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 173. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 174. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 175. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 176. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 177. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 178. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 179. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 180. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 181. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 182. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 183. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 184. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 185. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 186. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 187. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 188. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 189. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 190. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 191. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 192. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 193. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 194. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 195. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 196. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 197. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 198. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 199. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 200. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 201. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 202. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 203. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 204. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 214. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 215. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 216. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 217. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 218. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 219. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 220. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 221. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 222. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 223. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 224. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 225. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 226. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 227. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 228. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 229. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 230. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 231. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 232. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 233. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 234. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 235. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 236. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 237. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 238. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 239. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 240. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 241. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 242. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 243. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 244. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 245. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 246. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 247. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 248. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 249. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 250. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 251. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 252. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 253. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 254. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 255. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 256. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 257. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 258. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 259. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 260. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 261. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 262. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 263. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 264. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 265. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 266. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 267. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 268. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 269. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 270. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 271. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 272. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 273. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 274. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 275. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 276. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 277. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 278. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 279. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 280. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 281. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 282. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 283. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 284. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 285. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 286. NORWAY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 287. NORWAY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 288. NORWAY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 289. NORWAY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 290. NORWAY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 291. NORWAY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 292. NORWAY VITAL PROTEINS FOR BIOMANUFACTURING M

Companies Mentioned

Abcam PLC
Abnova Corporation
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
BioLegend, Inc. by PerkinElmer, Inc.
Biologics International Corporation
BPS Bioscience, Inc.
Bristol-Myers Squibb Company
Creative BioMart Inc.
Croyez Bioscience Co., Ltd.
Eli Lilly and Company
Enzo Life Sciences, Inc.
GenScript Biotech Corporation
Johnson & Johnson Services, Inc.
Laurus Bio Private Limited
LenioBio GmbH
Lonza Group AG
Merck KGaA
Meridian Bioscience, Inc. by SD Biosensor Inc.
Miltenyi Biotec B.V. & Co. KG
Novartis AG
ProMab Biotechnologies, Inc.
Thermo Fisher Scientific Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	187
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 56.52 Billion
Forecasted Market Value ( USD ) by 2030	$ 94.81 Billion
Compound Annual Growth Rate	8.9%
Regions Covered	Global
No. of Companies Mentioned	23

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3263EUR$3,374USD£2,763GBP €3625EUR$3,749USD£3,070GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4133EUR$4,274USD£3,500GBP €4593EUR$4,749USD£3,889GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5004EUR$5,174USD£4,238GBP €5560EUR$5,749USD£4,708GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5874EUR$6,074USD£4,975GBP €6527EUR$6,749USD£5,527GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7615EUR$7,874USD£6,449GBP €8461EUR$8,749USD£7,165GBP

Regional Insights

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Next-Generation Biomanufacturing Market by Type (Continuous Upstream Biomanufacturing, Downstream Biomanufacturing, Single-Use Upstream Biomanufacturing), Application (Hormones, Monoclonal Antibodies, Recombinant Proteins), End-User - Forecast 2024-2030

Global Digital Biomanufacturing Market by Deployment (Cloud, On-premises), Application (Antibodies, Cell & Gene Therapies, Proteins), End-use - Forecast 2024-2030

Biomanufacturing Viral Detection and Quantifications Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

Digital Biomanufacturing Global Market Report 2024

Cell and Gene Therapy Biomanufacturing CDMO Market - Focused on AAV - A Global and Regional Analysis: Focus on Phase of Development, Workflow, Indication, Culture Type, and Region - Analysis and Forecast, 2023-2033